I tuned into the webcast. Obviously, no mention of Lexaria, however there were a few comments made about the product on! and something about adjusting it for the FDA (don't quote me on this...I need to go back and listen a second time). A ton of the questions after the presentation were about decreasing costs and keeping future product costs down. Obvious I could speculate that there is still something going on between the two companies...but there is just no proof. I email Altria Investor Relations a while ago and they told me to talk to Chris. I keep checking the SEDAR and EDGAR pages for announcements...no dice. With it being the last day in April it would be nice for Chris to follow up on his comments regarding 'Altria decision by the end of April'...even if it just to announce that the decision date defined in the agreement has been extended due to new executive management at Altria and/or the COVID19 situation.
You didn't really expect MO to announce something with Lexy in their CC? I listened and they didn't. They did talk a lot about their ON product and it seems to be going very well. Would be the best fit of their current products with DehydraTECH.
Market Data 
Markets 
AI
